USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Trends in Communicable and Non-Communicable Diseases Drug Pipeline
Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global demand for immunoglobulin is growing and the market is expected to foresee increased competition. As of 2015, more than 40 immunoglobulin treatments have been approved, with another 28 in various stages of development. This research service provides an overview of the marketed products and those in the pipeline. The analysis divides these treatments by the communicable and non-communicable diseases that they treat. In addition, key products and companies are profiled.
Key Findings
Key Findings (continued)
Major Milestones
Major Milestones (continued)
Scope of the Study
Immunoglobulin Overview
Classification of Immunoglobulins
Classification of Immunoglobulins (continued)
Treatment Guidelines
Treatment Guidelines (continued)
Market Overview
Market Overview (continued)
Market Overview (continued)
Overview of Drugs
Overview of Drugs (continued)
Competitive Landscape—Communicable Diseases Treatments
Competitive Landscape—Non-Communicable Diseases Treatments
Communicable Diseases Product Overview
Marketed Product Analysis
Marketed Product Analysis (continued)
Marketed Product Analysis (continued)
Marketed Product Analysis (continued)
Marketed Product Analysis (continued)
Marketed Product Analysis (continued)
Pipeline Product Analysis
Pipeline Product Analysis (continued)
Non-Communicable Diseases Product Overview
Marketed Product Analysis
Marketed Product Analysis (continued)
Marketed Product Analysis (continued)
Pipeline Product Analysis
Pipeline Product Analysis (continued)
Hizentra—CSL Behring
Civacir—Biotest
Flebogamma 10%—Grifols
GAMUNEX-C—Grifols
Privigen—CSL Behring
VariZIG—Cangene
Hepabulin IV—SK Holdings
Zutectra—Biotest
HyperTET—Grifols
Baxter International Inc.
Biotest AG
China Biologics Products, Inc.
CSL Behring Limited
Grifols
Octapharma AG
Kedrion Biopharma
Estimated Key Product Launch Timeline
Approval Dates
Conclusions—Future of Immunoglobulin Market
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related industry research
16 Sep 2026 | North America | Customer Research
US Automotive Technicians’ Choice Survey, 2025
The 2025 US Automotive Technicians’ Choice study is an insightful voice-of-customer survey that highlights the tool preferences of automotive aftermarket service technicians. The survey of 400 automotive technicians across the United States used a combination of computer-assisted telephone and compu...
16 Sep 2026 | Global | Market Research
Apple Performance Tracker, Q1 2026
This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. It includes historical quarterly data for all t...
15 Sep 2026 | Global | Technology Research
Growth Opportunities in Workload Identity and Access Management, Non-Human Identity Security, Threat Exposure Management, and Blockchain Security
This edition of the Cyber Security Technology Opportunity Engine (TOE) showcases emerging cybersecurity innovators advancing AI-powered security, identity and access management, data security, threat exposure management, blockchain security, cyber incident response, network protection, and agentic A...
15 Sep 2026 | South Asia, Middle East & North Africa | Market Research
Future of Growth and Emerging Opportunities in the Gulf Cooperation Council, 2025–2030
The GCC has entered a period of strategic economic transformation as governments accelerate diversification efforts, strengthen economic resilience, and reduce dependence on hydrocarbon revenue amid heightened geopolitical uncertainty and evolving global trade dynamics. While the implications of the...
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Aish Vivekanadan |
| WIP Number | P8C1-01-00-00-00 |
| Keyword 1 | Global Immunoglobulin |
| Keyword 2 | Pipeline Analysis of the Immunoglobulin |
| Keyword 3 | Immunoglobulin Products |
| Is Prebook | No |
A Product and Pipeline Analysis of the Global Immunoglobulin Market
$4,950.00
Special Price $3,712.50 save 25 %